Increased cancer risk in patients with inflammatory and infectious diseases has been reported in many studies and lung cancer-associated empyema in <0.3% patients.
| INTRODUCTION
The incidence of pleural empyema as a primary finding in lung cancer patients is low (0.1%-0.3%), and only a few references on its management and outcome are reported in the literature. 1 We describe the case of a patient with empyema in whom the final pathology result was metastatic adenocarcinoma of the lung.
| CASE PRESENTATION
A 59-year-old female presented to the emergency department with a 3-week history of dyspnea, vomiting, and productive cough with one episode of hemoptysis. On admission, blood pressure was 132/80 mm Hg; pulse rate was 106/min, and 
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pleural biopsies showed an acute necrotizing inflammatory background and diffuse inflammation for which thoracoscopy was converted into thoracotomy and lung decortications were performed. Unexpectedly, definitive histology showed pleural metastatic adenocarcinoma of the lung.
| DISCUSSION
Pleural-thoracic empyema (commonly referred simply as empyema) or pyothorax refers to an infected purulent and often loculated pleural effusion and is the cause of a large unilateral pleural collection. It is a potentially life-threatening condition requiring prompt diagnosis and treatment. 2, 3 Empyema is usually the complication of another underlying abnormality and may occur in about 5% of cases of pneumonia. Primary lung cancer with associated empyema has been reported in <0.3% patients. In most cases, it is very difficult to obtain a diagnosis of empyema associated with lung cancer before surgery, and often it is a surprise of definitive histology, as in our case. 4 The prognosis is significantly worsened when pleural metastasis is found.
| CONCLUSION
Physicians must be aware of a possible presence of cancer when patients with empyema are refractory to standard treatment. Studies on pleural fluid including leukocyte counts and cultures, cytological examinations, and neoplasm markers must be planned. Studies on pleural fluid including leukocyte counts and cultures, cytological examinations, and markers of malignancy must be planned.
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